Results for tag: "Androgen Agonist"

The Androgen Agonist market is a subset of the Endocrine and Metabolic Disorders Drugs market. Androgen Agonists are drugs that mimic the effects of androgens, a type of hormone that is important for the development and maintenance of male characteristics. These drugs are used to treat a variety of conditions, including hypogonadism, prostate cancer, and delayed puberty. They can also be used to treat certain types of anemia and to increase muscle mass in certain conditions. Androgen Agonists are available in a variety of forms, including oral tablets, injectable solutions, and topical gels. Commonly prescribed Androgen Agonists include testosterone, dihydrotestosterone, and nandrolone. Some companies in the Androgen Agonist market include AbbVie, Eli Lilly, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more